Mansfield, Mass.-based medical products conglomerate Covidien plc inked a sole-source agreement with the Upper Midwest Consolidated Service Center and Mayo Clinic for its anti-deep vein thrombosis products.
Covidien’s Kendall SCD Sequential Compression System and A-V Impulse System Foot Pump will be distributed in 122 hospitals across 10 states.
Covidien’s medical device division continued to post strong numbers in the second quarter, boosting profits by 125 percent over the first quarter despite a 5 percent hit to the top line, largely on lost sales of its generic Oxycontin drug.